Skip to main content Skip to footer

Supply Chain & Operations Services for life sciences

Delivering end-to-end supply chain strategy and transformation

LIFE SCIENCES SUPPLY CHAIN

Achieving the elusive patient-centric supply chain

READ MORE

Supply chain resilience by design

New Science, the growth engine for the biopharma industry, helped us get through the pandemic, but inevitably added complexity and cost. The industry’s ability to adapt, lead, and thrive has activated a mindset shift from operational efficiency in individual silos, to resiliency through collaboration across silos and innovation at speed. It must be a multi-disciplinary task between R&D, regulatory affairs, procurement, manufacturing, quality, logistics and supply chain planners, united to deliver and create a more agile, resilient and sustainable pharma supply chain.

Accenture has the experience to help create future-ready life sciences supply chains that deliver across three key priorities:

  • Relevant – agile and customer-centric, addressing demand changes and scientific advances in a cost effective way
  • Resilient – preparing for, mitigating and responding to disruptions of all scales and constantly adapting to the ever-increasing complexity of New Science
  • Responsible – converting scientific advances to high quality medicines available globally by building sustainable value chains, positively impacting society and the planet while enhancing trust

Discover how we can help you sustain life sciences supply chain operations today and mobilize for tomorrow’s scientific advances and growth.

A new era in supply chain CMO collaboration

According to our research, 60% of life sciences supply chain executives (pharma/biopharma/medical device) struggle to get real-time inventory and visibility from external manufacturing partners. And yet, nearly all of them plan to expand their use of contract manufacturers in the next three years. This growth and increased complexity in life sciences supply chains requires an entirely different approach to collaboration to meet the demands of New Science and personalized treatments and devices.

In this report we bring to light the similarities and differences in the challenges both parties face and share real-world examples of where digital technology can help solve collaboration pain points. The report features companies who are getting it right and four key steps to establish a new level of supply chain collaboration.

Capabilities

Our supply chain & operations capabilities are designed to help clients achieve visibility and act with agility now to become a more responsive and resilient organization.

Patient-centric supply chain

As pharmaceutical complexity grows, building an intelligent supply chain in life sciences is critical and starts with re-thinking its design.

Closed loop spend management

Helping companies improve their customer experience, profitability and create responsible and resilient organizations.

Digital production and quality

Solving for increased digital complexity with modern product and platform engineering approaches to accelerate design, prototyping and testing.

Digital manufacturing & quality

Helping life sciences companies with the complexity and variability of products and therapeutic modalities to transform manufacturing and quality.

Sustainability Services

Tackle your greatest sustainability challenges and realize the competitive advantage and impact at scale.

A game-changing pharma supply chain network

When the pandemic struck, developing and deploying effective and safe vaccines as quickly as possible was a top priority. Pharmaceutical companies mobilized to create, test and get vaccines out the door to millions of people rapidly and safely. One leading biopharmaceutical company set out to be the first, rapidly developing a mRNA-based drug. Working in parallel they needed to scale up manufacturing and build a new supply chain network at record speed. As drug development progressed it became clear a game-changing new supply chain network was needed to enable lightspeed delivery and safe handling of a unique new cold chain drug. By identifying current state bottlenecks, automation opportunities and continuous improvement opportunities, we’ve helped prepare the company for ongoing vaccine supply, new formulation launches and created a blueprint for rapid future mRNA product launches.

Life Sciences

Vaccine supply chain network facilitation

With the pandemic, a game-changing new pharma supply chain network was needed for lightspeed delivery and safe handling of a unique new cold chain drug.

Read More

What we think

VIEW MORE ARTICLES
Life Sciences Supply Chain

New Science and cold chain

Cold chain capabilities need to grow with therapeutic innovations to satisfy patient demand. But how can they mature and scale at speed?

Supply Chain

Achieving the elusive patient-centric supply chain

A patient-centric supply chain requires that biopharma companies go beyond digitizing their supply chain and put patients at the center of operations.
VIEW MORE ARTICLES

Related pharma supply chain blogs

Accenture supply chain services helps life sciences companies build streamlined supply chains to increase profitability and respond to market challenges. Here are some of our thought leaders weighing in on the topic.

VIEW MORE POSTS
Life Sciences

The power of Generative AI in transforming the life sciences supply chain

Learn how Generative AI in life sciences supply chains enhances efficiency, decision-making, and competitiveness.

READ MORE
Life Sciences

Bridging the gap- Alignment of quality and supply chain

This blog helps to reimagine digital collaboration and ways of working across Quality and Supply Chain to reduce cycle times and supply risk.

READ MORE
VIEW MORE POSTS

Our leaders

Anne Marie O'Halloran

Managing Director – Life Sciences, Global Supply Chain and Industry X
LinkedIn

Carly Guenther

Managing Director – Strategy & Consulting, Supply Chain & Operations, Customer-Centric Supply Chain Lead
LinkedIn

Barry Heavey

Managing Director – Life Sciences, EMEA
LinkedIn

Debmalya Chatterjee

Managing Director – MedTech Lead, Southeast Asia
LinkedIn

Frequently asked questions

Operations resilience is more than having business continuity plans, rather it is focused on supporting current and future business ambitions. Intentional actions towards resilient operations position companies for growth and agility.

The global pandemic, geopolitical destabilizations and climate challenge our clients’ supply chains and operations. There is an opportunity to take the learnings and technological advances to drive greater resiliency. Resilience is essential for the industry to continue to shatter orthodoxy and create new pathways for innovation, access and affordability.

Yes. Life sciences companies can achieve operations resilience by developing a blueprint to define the path, designing and implementing the workforce, business process and technology backbone and operationalize to sustain value and redirect key talent to strategic efforts.